Trial Profile
A Post-marketing Surveillance for Safety and Adherence to Treatment of Enbrel in Adults With Psoriatic Arthritis in Belgium.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Aug 2015
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Psoriatic arthritis
- Focus Adverse reactions
- Acronyms PROVE
- Sponsors Pfizer; Wyeth
- 23 Jul 2015 Results published in the Clinical and Experimental Rheumatology.
- 11 Jul 2012 Actual end date (Apr 2012) added as reported by ClinicalTrials.gov.
- 15 Jun 2012 Planned end date changed from 1 May 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.